Maximizing Efficiency in
Your Laboratory Workflow
For Autoimmune, Infectious Disease, and Specialty Testing
Maximizing Efficiency in
Your Laboratory Workflow
For Autoimmune, Infectious Disease, and Specialty Testing
-
BioPlex 2200 TORCH Testing
The BioPlex 2200 System simplifies testing for congenital infections by combining eight independent tests into three panels for flexible and efficient testing.
BioPlex 2200 TORCH Testing – At a Glance
TORCH Testing for Congenital Infections
TORCH infections can lead to congenital infections and may cause adverse outcomes in fetuses and newborns. While these infections may not cause significant illness in healthy adults, they can cause severe complications if transmitted to a fetus during pregnancy.1
TORCH testing includes Toxoplasma gondii, rubella, cytomegalovirus, and herpes simplex virus. Testing patients before pregnancy or during the prenatal period determines the immune status of the mother and identifies infections early.
The BioPlex 2200 System’s comprehensive menu offers flexible options for TORCH testing, including ToRC IgG, ToRC IgM, and HSV-1 & HSV-2 IgG.

-
Watch Our Labroots Webinar
Role of Serology for Congenital Infections and Vaccine-Preventable Diseases in the Prenatal Setting
In this educational webinar, our speakers provide an overview of congenital infections and the use of serological testing in detecting and preventing prenatal infections.
-
Guest Speakers
Alan Wu, PhD
Chief of Clinical Chemistry
and Toxicology Laboratories,
San Francisco General HospitalRussell Neuner, PhD
Research and Development Manager,
Clinical Immunology,
Bio-Rad Laboratories
Efficiency of Multiplex Testing
-
- Generate multiple results in a single test
- Consolidate test methods on a fully automated, random-access multiplex platform
- Eliminate manual and batch testing
- Reduce laboratory waste and optimize reagent storage
- Decrease send out testing to improve turnaround time
Streamline TORCH Testing
Minimize laboratory effort
The BioPlex 2200 System uses multiplex technology to deliver more results with fewer tests.
-
Confidence in Results
- Verification of assay performance and result integrity in every test
- Simplified workflow with full automation
- Ready to use reagents, calibrators, and controls to minimize errors
- Reliability in patient results driven by strong assay precision
- Strong agreement with CDC disease specific panels and quantitative test results correlated to WHO standards
More Results, Less Effort.
Flexibility in Testing
Easily order multiple assays from a single test kit
Increase Laboratory Efficiency
Consolidate eight individual tests into three multiplex panels to simplify laboratory workflow and minimize effort
Report Results Confidently
Ensure high quality results with full automation and verification of assay performance in every test
Toxoplasma, Rubella and Cytomegalovirus (ToRC)
BioPlex 2200 ToRC IgG
For simultaneous detection and differentiation of antibodies to Toxoplasma gondii, rubella and cytomegalovirus.
- Toxoplasma gondii lgG (quantitative)
- Rubella lgG (quantitative)
- Cytomegalovirus lgG (qualitative)
BioPlex 2200 ToRC IgG is not available in PK.
Please contact your local sales office for any product questions.*
Toxoplasma, Rubella and Cytomegalovirus (ToRC)
BioPlex 2200 ToRC IgM
For simultaneous detection and differentiation of antibodies to Toxoplasma gondii, rubella and cytomegalovirus.
- Toxoplasma gondii lgM (qualitative)
- Rubella lgM (qualitative)
- Cytomegalovirus lgM (qualitative)
BioPlex 2200 ToRC IgM is not available in AU.
Please contact your local sales office for any product questions.*
Herpes Simplex Virus
BioPlex 2200 HSV-1 & HSV-2 IgG
For simultaneous detection and differentiation of the two most clinically relevant HSV antibodies HSV-1 and HSV-2 IgG.
- HSV-1 IgG
- HSV-2 IgG
BioPlex 2200 HSV-1 and HSV-2 IgG s not available in NZ.
Please contact your local sales office for any product questions.*
References
- Neu N et al. (2015). TORCH infections. Clinics in perinatology 42, 77-103.
- Samies NL et al. (2021). Neonatal herpes simplex virus disease: updates and continued challenges. Clinics in perinatology 48, 263-274.
- Arnold KC and Flint CJ (2017). Cytomegalovirus, Parvovirus B19, Varicella Zoster, and Toxoplasmosis in Pregnancy. Obstetrics Essentials 199-207.
Disclaimer
* These pages list our product offerings in these areas. Some products have limited regional availability. If you have a specific question about
products available in your area, please contact your local sales office or representative.